| Cardiovascular Risk Management |
1 |
1 |
| Cardiovascular Imaging |
0 |
0.72 |
| Heart Failure (HF) |
0 |
0.61 |
| Ejection Fraction |
0 |
0.55 |
| Coronary Artery Disease (CAD) |
0 |
0.52 |
| Genomic Medicine |
0 |
0.47 |
| Atherosclerosis |
0 |
0.36 |
| Heart |
0 |
0.36 |
| Lipids Management |
0 |
0.35 |
| Leukemia |
0 |
0.29 |
| Cancer |
0 |
0.26 |
| Blood |
0 |
0.18 |
| Cardiovascular disease |
0 |
0.99 |
| Clinical Research |
0 |
0.18 |
| Concerns of Elderly |
0 |
0.18 |
| CRISPR |
0 |
0.18 |
| Geriatrics |
0 |
0.18 |
| Hematologic Malignancies |
0 |
0.18 |
| Hospital |
0 |
0.18 |
| Massachusetts |
0 |
0.18 |
| Neoplasm |
0 |
0.18 |
| Risk Management |
0 |
0.18 |
| Healthcare and Medical Technology |
0 |
0.17 |
| Stem Cell Research and Therapy |
0 |
0.17 |